Tenaya Therapeutics, Inc.

NasdaqGS:TNYA Stock Report

Market Cap: US$132.3m

Tenaya Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:TNYA Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
18 Nov 24SellUS$4,787Chihiro SaitoIndividual2,258US$2.12
16 Aug 24SellUS$21,500Whittemore TingleyIndividual7,428US$2.89
16 Aug 24SellUS$28,216Faraz AliIndividual9,748US$2.89
16 Aug 24SellUS$6,840Chihiro SaitoIndividual2,363US$2.89
16 Feb 24SellUS$37,258Faraz AliIndividual6,358US$5.86
16 Feb 24SellUS$30,478Leone PattersonIndividual5,201US$5.86
16 Feb 24SellUS$38,090Whittemore TingleyIndividual6,500US$5.86
16 Feb 24SellUS$27,431Timothy HoeyIndividual4,681US$5.86
12 Feb 24BuyUS$9,999,999The Column Group, LLCCompany2,222,222US$4.50

Insider Trading Volume

Insider Buying: TNYA insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of TNYA?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders938,3281.18%
General Public20,302,69825.6%
VC/PE Firms23,115,84829.2%
Institutions34,863,64244%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 16.3%.

Top Shareholders

Top 25 shareholders own 67.85% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
11.9%
The Column Group, LLC
9,400,290US$15.7m0%26.13%
8.81%
RA Capital Management, L.P.
6,982,587US$11.7m-8.39%0.12%
8.5%
Casdin Capital, LLC
6,732,971US$11.2m0%0.63%
5.18%
BlackRock, Inc.
4,106,305US$6.9m0.79%no data
4.06%
The Vanguard Group, Inc.
3,213,167US$5.4m1.55%no data
3.82%
T. Rowe Price Group, Inc.
3,028,435US$5.1m-13.8%no data
3.25%
Octagon Capital Advisors LP
2,576,200US$4.3m0%0.6%
3%
Integral Health Asset Management, LLC
2,375,000US$4.0m2.15%0.45%
2.95%
Citadel Advisors LLC
2,335,151US$3.9m8.96%no data
1.96%
VR Adviser, LLC
1,555,556US$2.6m0%0.11%
1.89%
Ghost Tree Capital, LLC
1,500,000US$2.5m11.1%0.84%
1.7%
FMR LLC
1,345,938US$2.2m1.93%no data
1.64%
Geode Capital Management, LLC
1,296,156US$2.2m5.45%no data
1.34%
State Street Global Advisors, Inc.
1,058,898US$1.8m0.91%no data
1.28%
Euclidean Capital LLC
1,015,705US$1.7m0%0.16%
1.16%
Schonfeld Strategic Advisors LLC
917,370US$1.5m157%0.01%
1.16%
GV Management Company, LLC
915,705US$1.5m0%0.09%
0.71%
Deepak Srivastava
564,101US$942.0k0%no data
0.7%
abrdn plc
550,700US$919.7k0%no data
0.58%
StepStone Group Inc.
462,163US$771.8k0%0.19%
0.56%
Northern Trust Global Investments
444,847US$742.9k12.9%no data
0.48%
Renaissance Technologies LLC
380,468US$635.4k142%no data
0.43%
Jacobs Levy Equity Management Inc
337,265US$563.2k204%no data
0.41%
Millennium Management LLC
328,675US$548.9k17.1%no data
0.41%
Adage Capital Management, L.P.
324,245US$541.5k-67.6%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 00:12
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Tenaya Therapeutics, Inc. is covered by 10 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Whitney IjemCanaccord Genuity
Yevgeniya LivshitsChardan Capital Markets, LLC
Emanuela BranchettiH.C. Wainwright & Co.